UCK2 and hepatocellular carcinoma: Wu et al. reported that downregulation of UCK2 induces cell cycle arrest and activates the TNFα/NF-κB signaling pathway-related senescence-associated secretory phenotype to modify the tumor microenvironment and could improve the response to immunotherapy in patients with HCC [28].